Home > Insider Trading > Filing (0000899243-18-003580)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1605065	Brian Mcdonough	28 Esplanade St Helier Y9 JE2 3QA		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2018-02-08	10,000	$3.87	47,747	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Ordinary Share Option (Right to Buy)	$8.00		2024-04-29	10,000	10,000	Direct
Ordinary Shares	Options to purchase ordinary shares	$0.00	2022-11-14	2022-08-30	40,029	40,029	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$9.95		2024-10-31	5,025	5,025	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$11.62		2025-10-31	4,303	4,303	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$5.73		2026-10-31	8,726	8,726	Direct
Ordinary Shares	Restricted Stock Units	$0.00			2,618	2,618	Direct
Ordinary Shares	Warrant	$5.80		2018-07-31	10,493	10,493	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$5.21		2027-10-31	9,597	9,597	Direct
Ordinary Shares	Restricted Stock Units	$0.00			5,758	5,758	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-04-29	10,000	10,000	Direct
2022-08-30	40,029	40,029	Direct
2024-10-31	5,025	5,025	Direct
2025-10-31	4,303	4,303	Direct
2026-10-31	8,726	8,726	Direct
	2,618	2,618	Direct
2018-07-31	10,493	10,493	Direct
2027-10-31	9,597	9,597	Direct
	5,758	5,758	Direct

Footnotes

All 10,000 options have vested and remain exercisable.
The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
All 5,025 options have vested and remain exercisable.
2,868 options have vested and remain exercisable, 1,435 options will vest on October 31, 2018.
2,909 options vested on October 31, 2017 and remain exercisable, 2,909 options will vest on October 31, 2018, 2,908 options will vest on October 31, 2019.
Restricted Stock Units covert into ordinary shares on a one-for-one basis.
On October 31, 2016, the Reporting Person was granted 5,236 restricted stock units, of which 2,618 have vested and have been exercised. The remaining 2,618 restricted stock units will vest on October 31, 2018.
The warrants are immediately exercisable.
The options vest and become exercisable in three equal annual installments beginning October 31, 2018.
On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, vesting in two equal installments on October 31, 2018 and October 31, 2019.